[go: up one dir, main page]

EP0786999A4 - COMBINATION THERAPY FOR ACNE - Google Patents

COMBINATION THERAPY FOR ACNE

Info

Publication number
EP0786999A4
EP0786999A4 EP95936349A EP95936349A EP0786999A4 EP 0786999 A4 EP0786999 A4 EP 0786999A4 EP 95936349 A EP95936349 A EP 95936349A EP 95936349 A EP95936349 A EP 95936349A EP 0786999 A4 EP0786999 A4 EP 0786999A4
Authority
EP
European Patent Office
Prior art keywords
acne
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95936349A
Other languages
German (de)
French (fr)
Other versions
EP0786999A1 (en
Inventor
Joanne Waldstreicher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0786999A1 publication Critical patent/EP0786999A1/en
Publication of EP0786999A4 publication Critical patent/EP0786999A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP95936349A 1994-10-21 1995-10-17 COMBINATION THERAPY FOR ACNE Withdrawn EP0786999A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32717194A 1994-10-21 1994-10-21
US327171 1994-10-21
PCT/US1995/013305 WO1996012487A1 (en) 1994-10-21 1995-10-17 Combination method for acne treatment

Publications (2)

Publication Number Publication Date
EP0786999A1 EP0786999A1 (en) 1997-08-06
EP0786999A4 true EP0786999A4 (en) 1999-01-20

Family

ID=23275460

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95936349A Withdrawn EP0786999A4 (en) 1994-10-21 1995-10-17 COMBINATION THERAPY FOR ACNE

Country Status (5)

Country Link
EP (1) EP0786999A4 (en)
JP (1) JPH10508586A (en)
AU (1) AU694576B2 (en)
CA (1) CA2199979A1 (en)
WO (1) WO1996012487A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7442689B2 (en) 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
JP4526247B2 (en) * 2002-07-08 2010-08-18 第一三共株式会社 Oral cephalosporins
US20050136015A1 (en) * 2003-12-17 2005-06-23 McKie Derrick B. Topical use of halosalicylic acid derivatives
WO2008143761A1 (en) * 2007-05-14 2008-11-27 Sytheon Ltd. Sunscreen compositions and methods
CN107074716A (en) * 2014-07-18 2017-08-18 比奥考金特有限责任公司 Compositions and methods comprising salicylates and polysalicylates
KR20170134514A (en) 2015-03-23 2017-12-06 바이오팜엑스 인코포레이티드 Pharmaceutical Tetracycline composition for use in dermatology
IT201700060645A1 (en) * 2017-06-01 2018-12-01 Abiogen Pharma Spa USE OF XIBORNOL AS AN ACTIVE AGENT IN ACNE VOLGARE TREATMENT

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007586A1 (en) * 1990-10-31 1992-05-14 Beecham Group Plc Topical composition with retinoid penetration enhancer
WO1994020104A1 (en) * 1993-03-12 1994-09-15 Merck & Co, Inc. 15-substituted 4-azasteroids
WO1995011254A1 (en) * 1993-10-21 1995-04-27 Merck & Co., Inc. 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
WO1995013077A1 (en) * 1993-11-12 1995-05-18 Merck & Co., Inc. 7β-SUBSTITUTED-4-AZA-5α-CHOLESTAN-3-ONES AS SELECTIVE 5α-REDUCTASE 1 INHIBITORS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
AU4251993A (en) * 1992-05-20 1993-12-13 Merck & Co., Inc. Substituted 4-aza-5A-androstan-ones as 5A-reductase inhibitors

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007586A1 (en) * 1990-10-31 1992-05-14 Beecham Group Plc Topical composition with retinoid penetration enhancer
WO1994020104A1 (en) * 1993-03-12 1994-09-15 Merck & Co, Inc. 15-substituted 4-azasteroids
WO1995011254A1 (en) * 1993-10-21 1995-04-27 Merck & Co., Inc. 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
WO1995013077A1 (en) * 1993-11-12 1995-05-18 Merck & Co., Inc. 7β-SUBSTITUTED-4-AZA-5α-CHOLESTAN-3-ONES AS SELECTIVE 5α-REDUCTASE 1 INHIBITORS

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Pschyrembel Klinisches Wörterbuch", 1990, WALTER DE GRUYTER, BERLIN NEW YORK, XP002081095 *
"Rote Liste", 1991, EDITIO CANTOR, AULENDORF/WÜRTT., XP002065463 *
"Rote Liste", 1994, EDITIO CANTOR, AULENDORF/WÜRTT., XP002081096 *
"Rote Liste", 1994, EDITIO CANTOR, AULENDORF/WÜRTT., XP002081097 *
"The Merck Index, 11th ed.", 1989, MERCK & CO., INC, RAHWAY, N.J. (USA), XP002081094 *
See also references of WO9612487A1 *

Also Published As

Publication number Publication date
EP0786999A1 (en) 1997-08-06
CA2199979A1 (en) 1996-05-02
AU694576B2 (en) 1998-07-23
AU3833695A (en) 1996-05-15
WO1996012487A1 (en) 1996-05-02
JPH10508586A (en) 1998-08-25

Similar Documents

Publication Publication Date Title
DE69529857D1 (en) Radiotherapy System
ATE405273T1 (en) COMBINATION THERAPY FOR OSTEOPOROSIS
DE69524193D1 (en) MASSAGER
FI970762A0 (en) Spido-azabicyclic compounds useful in therapy
FI972194A7 (en) New benzylpyrimidines
NO950275D0 (en) Combination therapy for osteoporosis
BR9507784A (en) Electric regulator
FI942119A0 (en) Anordning i en gasblandare
KR960011768A (en) compiler
FI953710L (en) New pyrrolocarbazoles
DE69514764D1 (en) Massager
EP0786999A4 (en) COMBINATION THERAPY FOR ACNE
FI1516U1 (en) Foerpackning Foer i stapel anordnade smaoark
FI964532L (en) Cross-luminescence reduction
FI950864A0 (en) distribution Unit
DE69525334D1 (en) attrition
FI962961A0 (en) Telebetalningssystem i realtid
KR950032251U (en) Sauna structure for sauna
KR950031549U (en) Recessed outlet
KR960009986U (en) Massager
KR950024525U (en) Acupuncture
KR960006443U (en) Anion generator
KR960002525U (en) Anion generator
KR950026717U (en) Shiatsu
KR960020164U (en) Shiatsu

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970521

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19981203

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20001103

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010314